(Q34659357)

3 August 2017

1 reference

title

The vacuous chewing movement (VCM) model of tardive dyskinesia revisited: is there a relationship to dopamine D(2) receptor occupancy? (English)

1 reference

3 August 2017

1 reference

2

Gary Remington

1 reference

3 August 2017

Peter Turrone

1

1 reference

PubMed ID

12034136

3 August 2017

José N Nobrega

series ordinal

3

1 reference

3 August 2017

1 May 2002

1 reference

Neuroscience & Biobehavioral Reviews

3 August 2017

1 reference

3 August 2017

26

1 reference

3 August 2017

3

1 reference

3 August 2017

361-380

1 reference

Are animal studies of antipsychotics appropriately dosed? Lessons from the bedside to the bench

3 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Tardive drug-induced extrapyramidal syndromes

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Pharmacologic studies of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Schizophrenia, affective psychoses, and other disorders treated with neuroleptic drugs: the enigma of tardive dyskinesia, its neurobiological determinants, and the conflict of paradigms

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

1 reference

7 January 2021

Spontaneous orofacial movements induced in rodents by very long-term neuroleptic drug administration: phenomenology, pathophysiology and putative relationship to tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Prospective study of tardive dyskinesia incidence in the elderly

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Incidence and correlates of tardive dyskinesia in first episode of schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Tardive dyskinesia--reversible and persistent

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Intermittent neuroleptic treatment and risk for tardive dyskinesia: Curaçao Extrapyramidal Syndromes Study III.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

1 reference

7 January 2021

Identifying risk factors for tardive dyskinesia among long-term outpatients maintained with neuroleptic medications. Results of the Yale Tardive Dyskinesia Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Persistent tardive dyskinesia: demographic and pharmacological risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Chronic olanzapine or sertindole treatment results in reduced oral chewing movements in rats compared to haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Effects of clozapine and haloperidol on baseline levels of vacuous jaw movements in aged rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Intermittent versus continuous neuroleptic treatment in a rat model

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Persistent vacuous chewing in rats following neuroleptic treatment: relationship to dopaminergic and cholinergic function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Spontaneous chewing movements in rats during acute and chronic antipsychotic drug administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Spontaneous orofacial dyskinesia and dopaminergic function in rats after 6 months of neuroleptic treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Mixture in the distribution of haloperidol-induced oral dyskinesias in the rat supports an animal model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Intermittent and continuous haloperidol regimens produce different types of oral dyskinesias in rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Persistent oral dyskinesias in haloperidol-withdrawn neonatal 6-hydroxydopamine-lesioned rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Oral Dyskinesias and striatal lesions in rats after long-term co-treatment with haloperidol and 3-nitropropionic acid.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

The association of tardive dyskinesia and pseudoparkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Differential effects of continuous administration for 1 year of haloperidol or sulpiride on striatal dopamine function in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Pharmacological characterisation of spontaneous or drug-associated purposeless chewing movements in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Pharmacological and neurochemical differences between acute and tardive vacuous chewing movements induced by haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Scopolamine fails to diminish chronic haloperidol-induced purposeless chewing in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Delayed appearance of facial tics following chronic fluphenazine administration to guinea pigs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Dyskinesias Evoked in Monkeys by Weekly Administration of Haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Neurotoxicity associated with neuroleptic-induced oral dyskinesias in rats. Implications for tardive dyskinesia?

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Antipsychotic Drugs: Direct Correlation Between Clinical Potency and Presynaptic Action on Dopamine Neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Does fast dissociation from the dopamine d(2) receptor explain the action of atypical antipsychotics?: A new hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

The role of serotonin in antipsychotic drug action

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

5-HT2 and D2 receptor occupancy of olanzapine in schizophrenia: a PET investigation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

An experimental model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Increased dopamine D2 receptor binding after long-term treatment with antipsychotics in humans: a clinical PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Effects of chronic haloperidol on stress-induced oral behaviour in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Localized changes in GABA receptor-gated chloride channel in rat brain after long-term haloperidol: relation to vacuous chewing movements.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Quantitative autoradiography of striatal dopamine D1, D2 and re-uptake sites in rats with vacuous chewing movements.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

D1 and D2 receptor modulation in rat striatum and nucleus accumbens after subchronic and chronic haloperidol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Basal ganglia GABAA and dopamine D1 binding site correlates of haloperidol-induced oral dyskinesias in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Alterations in mRNA levels of D2 receptors and neuropeptides in striatonigral and striatopallidal neurons of rats with neuroleptic-induced dyskinesias.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Workshop on schizophrenia, PET, and dopamine D2 receptors in the human neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Use of positron emission tomography in analysing receptor function in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Neuroleptic-induced vacuous chewing movements in rodents: incidence and effects of long-term increases in haloperidol dose

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Autoradiographic mapping of mu opioid receptor changes in rat brain after long-term haloperidol treatment: relationship to the development of vacuous chewing movements

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Tardive dyskinesia: Behavioral effects of repeated intracerebroventricular haloperidol injections in rats do not confirm the kindling hypothesis

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

The dose-response characteristics of rat oral dyskinesias with chronic haloperidol or clozapine administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Neurochemical changes in the entopeduncular nucleus and increased oral behavior in rats treated subchronically with clozapine or haloperidol.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Chronic oral haloperidol and clozapine in rats: A behavioral evaluation.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Blind, controlled, long-term study of the comparative incidence of treatment-emergent tardive dyskinesia with olanzapine or haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Effect of chronic olanzapine treatment on striatal synaptic organization

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Risperidone-induced tardive dyskinesia in first-episode psychotic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Risperidone and tardive dyskinesia in organic psychosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Tardive dyskinesia during treatment with risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Tardive dyskinesia caused by the atypical antipsychotic risperidone and cured by the use of another drug of the same class, olanzapine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Tardive dyskinesia due to risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Risperidone-induced tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Neurologic side effects in neuroleptic-naive patients treated with haloperidol or risperidone

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Neuroleptic-induced vacuous chewing movements as an animal model of tardive dyskinesia: a study in three rat strains

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Estrogen receptor activation and tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Oral movement patterns induced in rats by local infusions into striatum depend upon the regimen of prior neuroleptic exposure.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Intermittent versus continuous stimulation: effect of time interval on the development of sensitization or tolerance

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Tremorous mouth movements in rats administered chronic neuroleptics

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Characteristics of oral movements in rats during and after chronic haloperidol and fluphenazine administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Rats administered chronic neuroleptics develop oral movements which are similar in form to those in humans with tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Oral dyskinesia in brain-damaged rats withdrawn from a neuroleptic: Implication for models of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

The effect of chronic neuroleptic administration on cerebral dopamine receptor function

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Oral dyskinesias and morphological changes in rat striatum during long-term haloperidol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Haloperidol-induced vacuous chewing in rats: suppression by alpha-methyl-tyrosine

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Effects of subthalamic nucleus lesions in a putative model of tardive dyskinesia in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Ultrastructural correlates of haloperidol-induced oral dyskinesias in rat striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Neuroleptic-induced chewing movements in the rat are suppressed by peripherally but not centrally administered CCK and abolished by bilateral subdiaphragmatic vagotomy

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Neurotensin and neurotensin analogues modify the effects of chronic neuroleptic administration in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Inhibition by memantine of the development of persistent oral dyskinesias induced by long-term haloperidol treatment of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Methylazoxymethanol (MAM)-induced brain lesion and oral dyskinesia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Chronic neuroleptic-induced mouth movements in the rat: suppression by CCK and selective dopamine D1 and D2 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

The opiate antagonist naloxone suppresses a rodent model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Reduction of nigral glutamic acid decarboxylase in rats with neuroleptic-induced oral dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Co-administration of progabide inhibits haloperidol-induced oral dyskinesias in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Effect of a dopamine D-1 agonist in rats treated chronically with zuclopenthixol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Persistent alterations in dendrites, spines, and dynorphinergic synapses in the nucleus accumbens shell of rats with neuroleptic-induced dyskinesias

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

The effects of raclopride on vacuous jaw movements in rats following acute administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Effects of ethanol in a putative rodent model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Enhancement of laminar FosB expression in frontal cortex of rats receiving long chronic clozapine administration.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Excitatory mechanisms in neuroleptic-induced vacuous chewing movements (VCMs): possible involvement of calcium and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Effects of neurotensin in a rodent model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Suppression of haloperidol-induced oral dyskinesias in rats by vigabatrin.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Decreased mu-opioid receptor binding in the globus pallidus of rats treated with chronic haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Effects of chronic naloxone administration on vacuous chewing movements and catalepsy in rats treated with long-term haloperidol decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Early suppression of striatal cyclic GMP may predetermine the induction and severity of chronic haloperidol-induced vacous chewing movements

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

FosB in rat striatum: normal regional distribution and enhanced expression after 6-month haloperidol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

The preventative role of antioxidants (selegiline and vitamin E) in a rat model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

No changes in dopamine D(1) receptor mRNA expressing neurons in the dorsal striatum of rats with oral movements induced by long-term haloperidol administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Striatal enlargement in rats chronically treated with neuroleptic.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Coenzyme Q10 does not prevent oral dyskinesias induced by long-term haloperidol treatment of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Regional brain changes in [3H]SCH 23390 binding to dopamine D1, receptors after long-term haloperidol treatment: lack of correspondence with the development of vacuous chewing movements.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Failure to down regulate NMDA receptors in the striatum and nucleus accumbens associated with neuroleptic-induced dyskinesia.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Correlation of vacuous chewing movements with morphological changes in rats following 1-year treatment with haloperidol

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Comparison of chronic administration of haloperidol and the atypical neuroleptics, clozapine and raclopride, in an animal model of tardive dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Study on the suitability of a rat model for tardive dyskinesia and the preventive effects of various drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Chronic haloperidol-induced alterations in pallidal GABA and striatal D(1)-mediated dopamine turnover as measured by dual probe microdialysis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Persistent catalepsy associated with severe dyskinesias in rats treated with chronic injections of haloperidol decanoate

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

The relationship between motor effects in rats following acute and chronic haloperidol treatment.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Effects of rating parameters on assessment of neuroleptic-induced vacuous chewing movements.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Oral dyskinesia in rats following brain lesions and neuroleptic drug administration

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Recording oral activity in rats reveals a long-lasting subsensitivity to haloperidol as a function of duration of previous haloperidol treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Assessment of striatal extracellular dopamine and dopamine metabolites by microdialysis in haloperidol-treated rats exhibiting oral dyskinesia

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Tremulous jaw movements in rats: a model of parkinsonian tremor.

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Striatal binding of 11C-NMSP studied with positron emission tomography in patients with persistent tardive dyskinesia: no evidence for altered dopamine D2 receptor binding

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

Acute dystonia induced by neuroleptic drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0149-7634%2802%2900008-8

7 January 2021

10.1016/S0149-7634(02)00008-8

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

12034136